Similar articles

• [Role of inhaled corticosteroids in the management of COPD].

  Chazan R. Chazan R. Pneumonol Alergol Pol. 2009;77(2):186-91. Pneumonol Alergol Pol. 2009. PMID: 19462354 Review. Polish. No abstract available.
• Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.

  Baker WL, Baker EL, Coleman CI. Baker WL, et al. Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891. Pharmacotherapy. 2009. PMID: 19637942
• [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!].

  Rochat T. Rochat T. Rev Med Suisse. 2008 Jan 16;4(140):155-7. Rev Med Suisse. 2008. PMID: 18309880 Review. French.
• Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.

  Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L. Cyr MC, et al. Ann Pharmacother. 2010 Apr;44(4):613-22. doi: 10.1345/aph.1M243. Epub 2010 Mar 16. Ann Pharmacother. 2010. PMID: 20233915
• Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease.

  Wang ZL. Wang ZL. Chin Med J (Engl). 2007 Jun 20;120(12):1097-105. Chin Med J (Engl). 2007. PMID: 17637229 Review. No abstract available.